Polymorphisms in PTEN in breast cancer families - PubMed (original) (raw)
Polymorphisms in PTEN in breast cancer families
B T Carroll et al. J Med Genet. 1999 Feb.
Erratum in
- J Med Genet 2000 Jul;37(7):559
Abstract
Germline mutations in PTEN are the underlying genetic defect in Cowden disease, which is associated with a lifetime risk of 25-50% of developing breast cancer. To investigate the role of PTEN in inherited breast cancer in the absence of manifestations of Cowden disease, we screened 177 unrelated subjects with breast cancer who also had a family history of breast cancer in at least one relative. We found no disease associated PTEN mutations in this cohort, supporting previous studies suggesting that PTEN mutations do not contribute to inherited susceptibility to breast cancer without associated manifestations of Cowden disease. We did identify an association between a common polymorphism in intron 4 and lower mean age of diagnosis of breast cancer. While preliminary, these findings suggest that further study is warranted to determine whether this allelic variant of PTEN could function as a low penetrance breast cancer susceptibility allele.
Similar articles
- Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI, Boyd J. Rhei E, et al. Cancer Res. 1997 Sep 1;57(17):3657-9. Cancer Res. 1997. PMID: 9288766 - Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.
Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Dahia PL, Zheng Z, Liaw D, Caron S, Duboué B, Lin AY, Richardson AL, Bonnetblanc JM, Bressieux JM, Cabarrot-Moreau A, Chompret A, Demange L, Eeles RA, Yahanda AM, Fearon ER, Fricker JP, Gorlin RJ, Hodgson SV, Huson S, Lacombe D, Eng C, et al. Marsh DJ, et al. Hum Mol Genet. 1998 Mar;7(3):507-15. doi: 10.1093/hmg/7.3.507. Hum Mol Genet. 1998. PMID: 9467011 - PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.
Marsh DJ, Kum JB, Lunetta KL, Bennett MJ, Gorlin RJ, Ahmed SF, Bodurtha J, Crowe C, Curtis MA, Dasouki M, Dunn T, Feit H, Geraghty MT, Graham JM Jr, Hodgson SV, Hunter A, Korf BR, Manchester D, Miesfeldt S, Murday VA, Nathanson KL, Parisi M, Pober B, Romano C, Eng C, et al. Marsh DJ, et al. Hum Mol Genet. 1999 Aug;8(8):1461-72. doi: 10.1093/hmg/8.8.1461. Hum Mol Genet. 1999. PMID: 10400993 - [Cowden disease].
Sawada T, Hamano N, Suzuki A, Okada T, Mabuchi H. Sawada T, et al. Nihon Rinsho. 2000 Jul;58(7):1479-83. Nihon Rinsho. 2000. PMID: 10921327 Review. Japanese. - Genetics of Cowden syndrome: through the looking glass of oncology.
Eng C. Eng C. Int J Oncol. 1998 Mar;12(3):701-10. doi: 10.3892/ijo.12.3.701. Int J Oncol. 1998. PMID: 9472113 Review.
Cited by
- PTEN gene polymorphisms and susceptibility to oral squamous cell carcinoma in a Chinese Han population.
Yang XD, Zhao SF, Zhang Q, Li W, Wang YX, Hong XW, Hu QG. Yang XD, et al. Tumour Biol. 2016 Jan;37(1):577-82. doi: 10.1007/s13277-015-3804-5. Epub 2015 Aug 2. Tumour Biol. 2016. PMID: 26232326 - Elevation of methylated DNA in KILLIN/PTEN in the plasma of patients with thyroid and/or breast cancer.
Ng EK, Shin VY, Leung CP, Chan VW, Law FB, Siu MT, Lang BH, Ma ES, Kwong A. Ng EK, et al. Onco Targets Ther. 2014 Nov 11;7:2085-92. doi: 10.2147/OTT.S53597. eCollection 2014. Onco Targets Ther. 2014. PMID: 25419146 Free PMC article. - Breast cancer in the era of integrating "Omics" approaches.
Rossi C, Cicalini I, Cufaro MC, Consalvo A, Upadhyaya P, Sala G, Antonucci I, Del Boccio P, Stuppia L, De Laurenzi V. Rossi C, et al. Oncogenesis. 2022 Apr 14;11(1):17. doi: 10.1038/s41389-022-00393-8. Oncogenesis. 2022. PMID: 35422484 Free PMC article. Review. - The association of phosphatase and tensin homolog deleted on chromosome 10 polymorphisms and lifestyle habits with colorectal cancer risk in a Chinese population.
Jing F, Mao Y, Zhang Z, Li Y, Cai S, Li Q, Ma X, Jin M, Chen K. Jing F, et al. Tumour Biol. 2014 Sep;35(9):9233-40. doi: 10.1007/s13277-014-2197-1. Epub 2014 Jun 17. Tumour Biol. 2014. PMID: 24935469 - Variants on the promoter region of PTEN affect breast cancer progression and patient survival.
Heikkinen T, Greco D, Pelttari LM, Tommiska J, Vahteristo P, Heikkilä P, Blomqvist C, Aittomäki K, Nevanlinna H. Heikkinen T, et al. Breast Cancer Res. 2011;13(6):R130. doi: 10.1186/bcr3076. Epub 2011 Dec 15. Breast Cancer Res. 2011. PMID: 22171747 Free PMC article.
References
- Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10325-9 - PubMed
- Am J Hum Genet. 1997 Dec;61(6):1254-60 - PubMed
- Nat Genet. 1996 May;13(1):114-6 - PubMed
- Nat Genet. 1996 May;13(1):123-5 - PubMed
- Science. 1997 Mar 28;275(5308):1943-7 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials